The webinar—Adverse Event Reporting (AER) for the Dietary Supplement Industry: Key Considerations from the Experts covered:
FDA’s response to AERs and what triggers agency action
Daniel Fabricant, Ph.D.
Director, Division of Dietary Supplement Programs, Office of Nutrition, Labeling and Dietary Supplements, Center for Food Safety and Applied Nutrition, FDA
Legal and regulatory requirements for dietary supplement businesses
Scott Bass
Partner, Sidley Austin LLP
Tony Young
Partner, Kleinfeld, Kaplan & Becker LLP
Preparations for receiving and recording an AER
Michael Lelah, Ph.D.
Technical Director, NOW Foods
Taking an AER
Steve Swantek
President & CEO, PROSAR
Q&A—get YOUR specific questions answered
Moderated by Scott Bass and Tony Young
|
